| Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ... Nature communications 11 (1), 157, 2020 | 343 | 2020 |
| A data-independent acquisition-based global phosphoproteomics system enables deep profiling RB Kitata, WK Choong, CF Tsai, PY Lin, BS Chen, YC Chang, ... Nature Communications 12 (1), 2539, 2021 | 70 | 2021 |
| Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling J Zecha, W Gabriel, R Spallek, YC Chang, J Mergner, M Wilhelm, ... Nature communications 13 (1), 165, 2022 | 62 | 2022 |
| Robust microflow LC-MS/MS for proteome analysis: 38 000 runs and counting Y Bian, FP Bayer, YC Chang, C Meng, S Hoefer, N Deng, R Zheng, ... Analytical chemistry 93 (8), 3686-3690, 2021 | 58 | 2021 |
| Localized inhibition of protein phosphatase 1 by NUAK1 promotes spliceosome activity and reveals a MYC-sensitive feedback control of transcription G Cossa, I Roeschert, F Prinz, A Baluapuri, RS Vidal, C Schülein-Völk, ... Molecular cell 77 (6), 1322-1339. e11, 2020 | 58 | 2020 |
| Mass spectrometry-based draft of the mouse proteome P Giansanti, P Samaras, Y Bian, C Meng, A Coluccio, M Frejno, ... Nature methods 19 (7), 803-811, 2022 | 46 | 2022 |
| Evaluation of disposable trap column nanoLC–FAIMS–MS/MS for the proteomic analysis of FFPE tissue S Eckert, YC Chang, FP Bayer, M The, PH Kuhn, W Weichert, B Kuster Journal of proteome research 20 (12), 5402-5411, 2021 | 21 | 2021 |
| Chemoproteomic target deconvolution reveals Histone Deacetylases as targets of (R)-lipoic acid S Lechner, RR Steimbach, L Wang, ML Deline, YC Chang, T Fromme, ... Nature Communications 14 (1), 3548, 2023 | 18 | 2023 |
| .(2020) Robust, reproducible and quantitative analysis of thousands of proteomes by microflow LC–MS/MS Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ... Nat. Commun 11, 157, 0 | 11 | |
| Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics YC Chang, C Gnann, RR Steimbach, FP Bayer, S Lechner, A Sakhteman, ... Cell reports 43 (6), 2024 | 6 | 2024 |
| UHMK1 is a novel splicing regulatory kinase VC Arfelli, YC Chang, JW Bagnoli, P Kerbs, FE Ciamponi, LMS Paz, ... Journal of biological chemistry 299 (4), 2023 | 5 | 2023 |
| Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS. Nat Commun. 2020; 11 (1): 157 Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ... | 5 | |
| Illuminating oncogenic KRAS signaling by multi-dimensional chemical proteomics N Kabella, FP Bayer, K Stamatiou, M Abele, A Sakhteman, YC Chang, ... bioRxiv, 2025.01. 30.635627, 2025 | | 2025 |
| A multi-omic screening approach identifies the E3-ubiquitin ligase DCAF13 as a novel vulnerability in lung adenocarcinoma VT Wagner, YC Chang, P Giansanti, R Öllinger, T Engleitner, B Kuster, ... Cancer Research 83 (7_Supplement), 2575-2575, 2023 | | 2023 |
| Synergistic Antileukemic Effect of Mek and Lsd1 Inhibitors Correlates with Decreased Phospho-Serine 315 of TP53 A Caroleo, P Kerbs, A Swoboda, L Wange, S Heinzlmeir, YC Chang, ... Blood 140 (Supplement 1), 5870-5871, 2022 | | 2022 |
| 基于高流速 LC 的蛋白质组学分析平台 Y Bian, R Zheng, YC Chang, J Zecha, S Heinzlmeir, DP Zolg, ... 中国化学会第 22 届全国色谱学术报告会及仪器展览会论文集 (第一卷), 2019 | | 2019 |
